✦ LIBER ✦

Phase II Trial of Carboplatin and Paclitaxel in Papillary Renal Cell Carcinoma

✍ Scribed by Kathryn A. Bylow; Michael B. Atkins; Edwin M. Posadas; Walter M. Stadler; David F. McDermott

Book ID: 115075982
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 109 KB
Volume: 7
Category: Article
ISSN: 1558-7673
DOI: 10.3816/cgc.2009.n.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of adjuvant pelvic radiat

Phase II trial of adjuvant pelvic radiation “sandwiched” between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma

✍ Mark H. Einstein; Marina Frimer; Dennis Y.-S. Kuo; Laura L. Reimers; Keyur Mehta 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Weekly dose-dense paclitaxel and carbopl

Weekly dose-dense paclitaxel and carboplatin in recurrent ovarian carcinoma: A phase II trial

✍ Shawky, Hanan; Tawfik, Hesham; Hewidy, Medhat 📂 Article 📅 2014 🏛 National Cancer Institute - Egypt 🌐 English ⚖ 557 KB

699 Phase II trial of paclitaxel and car

699 Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer

✍ M. Johannsen; A. Wille; J. Roigas; D. Schnorr; S. Loening 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 210 KB

Prospective phase II trial of adjuvant p

Prospective phase II trial of adjuvant pelvic radiation “sandwiched” between paclitaxel and carboplatin combination chemotherapy in women with uterine papillary serous carcinoma

✍ M. Einstein; M. Frimer; R. Phaeton; L. Reimers; K. Mehta; S. Mutyala; D. Kuo; G. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Phase II trial of carboplatin and paclit

Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study

✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local

Phase II trial of paclitaxel, ifosfamide

Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer

✍ Socinski, Mark A.; Neubauer, Marcus A.; Olivares, Jairo; Ketchel, Steven; Tynan, 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 157 KB